Big4Bio:Boston COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. Local: City […]

Read More

SPOTLIGHT: Big4Bio:Boston 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the Boston region! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in Boston’s research, pharma, and biotech industries as you look ahead to a fruitful 2020. Compared to 2018, life sciences venture investment fell in Boston and across the United […]

Read More

Big4Bio Interview with Halloran Consulting Group’s Laurie Halloran and Katie McCarthy

Boston-based Halloran Consulting Group offers senior-level expertise to life science companies as they navigate the regulatory, clinical, and operational challenges at each stage of their development. At the beginning of October, Halloran announced several promotions in its organization, and the expansion of operations in San Diego, setting up a West Coast office there to better […]

Read More

Spotlight: Catching Up With CO.DON AG CEO, Ralf Jakobs

LaVoieHealthScience Client Spotlight: CO.DON CEO, Ralf Jakobs — Advancing Autologous Human Cell Transplants   Can you provide a brief overview of CO.DON and its focus? CO.DON is focused on the development, production and marketing of cell-based products for joint-preserving, regenerative treatment of articular cartilage defects. That’s all we do and where we have built our […]

Read More

Spotlight: Q&A With Scott Grossman on ExL Events

ExL Events, a division of Questex, develops and hosts content-driven conferences and partnered events for life sciences industry professionals and academia that cover a breadth of topics from drug and device development issues and services, to hospital networks, communications, and human resources.  Their diverse event portfolio is backed by extensive market research and targeted outreach […]

Read More

An Update on Big4Bio’s LinkedIn Groups

As Big3Bio rebrands to Big4Bio, the organization’s LinkedIn presence will also be reshaped. LinkedIn groups have the potential to instigate meaningful discussions among members of the community. In the past, Big3Bio has cultivated three region–specific groups, Boston, San Diego, and SFBay. But with Big3Bio rebranding to Big4Bio, we have made the decision to unify the […]

Read More

Spotlight: Precision Medicine Decision-Making Support for Oncologists

Intervention Insight’s Trapelo is an innovative platform designed to resolve the complexities of precision medicine in real time. With an initial focus on cancer, where the treatment journey can involve complex and arduous processes, Trapelo aligns the priorities of oncologists, practices, labs, and payers within the practice workflow, eliminates the need for prior-authorization, and speeds […]

Read More

Spotlight: Q&A With Dr. Keith M. Astrofsky, DVM, Director of Operations of Mispro

Q&A on Mispro Insourcing Option Since 2003, Mispro Biotech Services has offered biopharmaceutical and life science companies access to state-of-the-art vivarium research space plus comprehensive laboratory animal science services supporting preclinical drug development. With more than 20 years’ experience in veterinary & animal laboratory sciences, with expertise in animal care & welfare, program accreditation & […]

Read More

Spotlight: Merrimack Pharmaceuticals – Auction of R&D Assets

Merrimack Pharmaceuticals: Auction of R&D Assets Auction Begins April 29th Register Now – 500+ Lots Available   Beginning Monday, April 29th, BioSurplus will conduct a timed online auction of research assets from the labs of Merrimack Pharmaceuticals in Cambridge, MA. This event features more than 500 lots of high-quality, late-model R&D lab equipment. Available lots include flow […]

Read More